165 related articles for article (PubMed ID: 25886928)
1. New-Onset Diabetes and Antiretroviral Treatments in HIV-Infected Adults in Thailand.
Riyaten P; Salvadori N; Traisathit P; Ngo-Giang-Huong N; Cressey TR; Leenasirimakul P; Techapornroong M; Bowonwatanuwong C; Kantipong P; Nilmanat A; Yutthakasemsunt N; Chutanunta A; Thongpaen S; Klinbuayaem V; Decker L; Le Cœur S; Lallemant M; Capeau J; Mary JY; Jourdain G
J Acquir Immune Defic Syndr; 2015 Aug; 69(4):453-9. PubMed ID: 25886928
[TBL] [Abstract][Full Text] [Related]
2. Ten-year diabetes incidence in 1046 HIV-infected patients started on a combination antiretroviral treatment.
Capeau J; Bouteloup V; Katlama C; Bastard JP; Guiyedi V; Salmon-Ceron D; Protopopescu C; Leport C; Raffi F; Chêne G;
AIDS; 2012 Jan; 26(3):303-14. PubMed ID: 22089377
[TBL] [Abstract][Full Text] [Related]
3. Associations of statins and antiretroviral drugs with the onset of type 2 diabetes among HIV-1-infected patients.
Spagnuolo V; Galli L; Poli A; Salpietro S; Gianotti N; Piatti P; Cossarini F; Vinci C; Carini E; Lazzarin A; Castagna A
BMC Infect Dis; 2017 Jan; 17(1):43. PubMed ID: 28061820
[TBL] [Abstract][Full Text] [Related]
4. Sustainability of first-line antiretroviral regimens: findings from a large HIV treatment program in western Kenya.
Braitstein P; Ayuo P; Mwangi A; Wools-Kaloustian K; Musick B; Siika A; Kimaiyo S
J Acquir Immune Defic Syndr; 2010 Feb; 53(2):254-9. PubMed ID: 19745752
[TBL] [Abstract][Full Text] [Related]
5. Incidence of diabetes mellitus in a population-based cohort of HIV-infected and non-HIV-infected persons: the impact of clinical and therapeutic factors over time.
Tripathi A; Liese AD; Jerrell JM; Zhang J; Rizvi AA; Albrecht H; Duffus WA
Diabet Med; 2014 Oct; 31(10):1185-93. PubMed ID: 24673640
[TBL] [Abstract][Full Text] [Related]
6. Chronic kidney disease and HIV in the era of antiretroviral treatment: findings from a 10-year cohort study in a west African setting.
Kaboré NF; Poda A; Zoungrana J; Da O; Ciaffi L; Semdé A; Yaméogo I; Sawadogo AB; Delaporte E; Meda N; Limou S; Cournil A
BMC Nephrol; 2019 May; 20(1):155. PubMed ID: 31064340
[TBL] [Abstract][Full Text] [Related]
7. A randomized study comparing triple versus double antiretroviral therapy or no treatment in HIV-1-infected patients in very early stage disease: the Spanish Earth-1 study.
García F; Romeu J; Grau I; Sambeat MA; Dalmau D; Knobel H; Gomez-Sirvent JL; Arrizabalaga J; Cruceta A; Clotet BG; Podzamczer D; Pumarola T; Gallart T; O'Brien WA; Miró JM; Gatell JM
AIDS; 1999 Dec; 13(17):2377-88. PubMed ID: 10597779
[TBL] [Abstract][Full Text] [Related]
8. The role of nucleoside and nucleotide analogues in nodular regenerative hyperplasia in HIV-infected patients: a case control study.
Cotte L; Bénet T; Billioud C; Miailhes P; Scoazec JY; Ferry T; Brochier C; Boibieux A; Vanhems P; Chevallier M; Zoulim F
J Hepatol; 2011 Mar; 54(3):489-96. PubMed ID: 21056493
[TBL] [Abstract][Full Text] [Related]
9. Prevalence, incidence and predictors of peripheral neuropathy in African adults with HIV infection within the DART trial.
Kiwuwa-Muyingo S; Kikaire B; Mambule I; Musana H; Musoro G; Gilks CF; Levin JB; Walker AS
AIDS; 2014 Nov; 28(17):2579-88. PubMed ID: 25574960
[TBL] [Abstract][Full Text] [Related]
10. A survey of the syntheses of active pharmaceutical ingredients for antiretroviral drug combinations critical to access in emerging nations.
Pinheiro Edos S; Antunes OA; Fortunak JM
Antiviral Res; 2008 Sep; 79(3):143-65. PubMed ID: 18571246
[TBL] [Abstract][Full Text] [Related]
11. Treatment Failure in HIV-Infected Children on Second-line Protease Inhibitor-Based Antiretroviral Therapy.
Suaysod R; Ngo-Giang-Huong N; Salvadori N; Cressey TR; Kanjanavanit S; Techakunakorn P; Krikajornkitti S; Srirojana S; Laomanit L; Chalermpantmetagul S; Lallemant M; Le Cœur S; McIntosh K; Traisathit P; Jourdain G
Clin Infect Dis; 2015 Jul; 61(1):95-101. PubMed ID: 25838288
[TBL] [Abstract][Full Text] [Related]
12. Incidence and risk factors for new-onset diabetes in HIV-infected patients: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study.
De Wit S; Sabin CA; Weber R; Worm SW; Reiss P; Cazanave C; El-Sadr W; Monforte Ad; Fontas E; Law MG; Friis-Møller N; Phillips A;
Diabetes Care; 2008 Jun; 31(6):1224-9. PubMed ID: 18268071
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naive patients: a 3-year randomized trial.
Gallant JE; Staszewski S; Pozniak AL; DeJesus E; Suleiman JM; Miller MD; Coakley DF; Lu B; Toole JJ; Cheng AK;
JAMA; 2004 Jul; 292(2):191-201. PubMed ID: 15249568
[TBL] [Abstract][Full Text] [Related]
14. Higher risk of hyperglycemia in HIV-infected patients treated with didanosine plus tenofovir.
García-Benayas T; Rendón AL; Rodríguez-Novóa S; Barrios A; Maida I; Blanco F; Barreiro P; Rivas P; González-Lahoz J; Soriano V
AIDS Res Hum Retroviruses; 2006 Apr; 22(4):333-7. PubMed ID: 16623636
[TBL] [Abstract][Full Text] [Related]
15. New-onset diabetes in HIV-treated adults: predictors, long-term renal and cardiovascular outcomes.
Putcharoen O; Wattanachanya L; Sophonphan J; Siwamogsatham S; Sapsirisavat V; Gatechompol S; Phonphithak S; Kerr SJ; Chattranukulchai P; Avihingsanon Y; Ruxrungtham K; Avihingsanon A;
AIDS; 2017 Jul; 31(11):1535-1543. PubMed ID: 28398958
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of emtricitabine vs stavudine in combination therapy in antiretroviral-naive patients: a randomized trial.
Saag MS; Cahn P; Raffi F; Wolff M; Pearce D; Molina JM; Powderly W; Shaw AL; Mondou E; Hinkle J; Borroto-Esoda K; Quinn JB; Barry DW; Rousseau F;
JAMA; 2004 Jul; 292(2):180-9. PubMed ID: 15249567
[TBL] [Abstract][Full Text] [Related]
17. Incidence and clinical outcomes of diabetes mellitus in HIV-infected adults in Thailand: a retrospective cohort study.
Paengsai N; Jourdain G; Chaiwarith R; Tantraworasin A; Bowonwatanuwong C; Bhakeecheep S; Cressey TR; Mary JY; Salvadori N; Kosachunhanun N
BMC Public Health; 2018 Aug; 18(1):1079. PubMed ID: 30165821
[TBL] [Abstract][Full Text] [Related]
18. Determinants of loss to follow-up among HIV positive patients receiving antiretroviral therapy in a test and treat setting: A retrospective cohort study in Masaka, Uganda.
Kiwanuka J; Mukulu Waila J; Muhindo Kahungu M; Kitonsa J; Kiwanuka N
PLoS One; 2020; 15(4):e0217606. PubMed ID: 32255796
[TBL] [Abstract][Full Text] [Related]
19. Longitudinal adherence to antiretroviral drugs for preventing mother-to-child transmission of HIV in Zambia.
Okawa S; Chirwa M; Ishikawa N; Kapyata H; Msiska CY; Syakantu G; Miyano S; Komada K; Jimba M; Yasuoka J
BMC Pregnancy Childbirth; 2015 Oct; 15():258. PubMed ID: 26459335
[TBL] [Abstract][Full Text] [Related]
20. A randomized, double-blind trial comparing combinations of nevirapine, didanosine, and zidovudine for HIV-infected patients: the INCAS Trial. Italy, The Netherlands, Canada and Australia Study.
Montaner JS; Reiss P; Cooper D; Vella S; Harris M; Conway B; Wainberg MA; Smith D; Robinson P; Hall D; Myers M; Lange JM
JAMA; 1998 Mar; 279(12):930-7. PubMed ID: 9544767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
